As a cast member on the television series “America’s Test Kitchen,” and host of its companion podcast “The Walk-In,” Elle Simone Scott delights in sharing her expertise and recipes. The Boston-based celebrity chef and food stylist is also a role model, as founder and president of SheChef, Inc., a professional networking organization for fellow women … Read more
Ovarian cancer almost always starts in the fallopian tubes. It’s counterintuitive. Why is it called ovarian cancer if it doesn’t start there? For a long time, the ovaries were assumed to be the source because that is where the cancer is concentrated at the time of diagnosis. But about 20 years ago, researchers took a … Read more
Millions of people regularly take or use contraceptives, such as birth control pills, to avoid unwanted pregnancy or relieve menstruation-related side effects such as cramps or heavy bleeding. There is some evidence that contraceptives may affect cancer risk — specifically, that oral contraceptives may increase the likelihood of developing breast and cervical cancers but reduce … Read more
A recent study found that women who frequently use chemical hair straighteners and relaxers could have a higher risk of developing uterine cancer than those who have not used the products. The study, which tracked 34,000 women nationwide for more than a decade, comes at a time when uterine cancer rates in women are increasing, … Read more
Uterine cancer — also known as endometrial cancer — has traditionally been classified as endometrioid or non-endometrioid based on the appearance of the tumor cells under a microscope. Now, as scientists learn more about the molecular makeup of the disease, uterine cancers are increasingly identified by the specific genetic alterations within them. Endometrioid uterine tumors … Read more
Over the years, a variety of studies have suggested that aspirin use is associated with reduced ovarian cancer rates, but a recent study filled in some important details, showing that frequent aspirin use is linked to a lower risk of the disease in people with multiple risk factors. The study, led by researchers at the … Read more
No one enjoys a gallbladder attack, but Karen Howley LaCamera is glad hers came when it did. Had sharp abdominal pains not sent her to the emergency room in February 2018, it may have been much longer before doctors discovered another major problem silently growing inside her: stage III ovarian cancer. “I think about that … Read more
Dana-Farber investigators recently launched a trial of a miniature device that can be implanted into ovarian tumors to deliver microdoses of different drugs, with the goal of rapidly measuring their effectiveness in killing cancer cells. The researchers hope the method could shorten the time needed to determine if a drug is helping a patient, and … Read more
Despite breakthrough treatments for high-grade serous ovarian cancer, about 80 percent of patients relapse within two years, often resistant to treatment. The good news is that Dana-Farber scientists are pursuing multiple avenues of research that very well may improve outcomes. “A number of patients develop progressive disease at a later point, potentially indicating that a … Read more
The time may not be far off when the treatment for a person’s ovarian cancer can be tailored to their malignancy using drugs selected by testing on “organoids” — miniature 3-D clusters of cancer cells grown from a patient’s own tumor cells. Although ovarian organoid tests are not yet being used to guide treatment decisions, … Read more
When Dana-Farber launched its new Center for BRCA and Related Genes in August 2020, it was with patients like Janice Dolnick in mind. Dolnick’s cancer journey had already been a long one before she came to Dana-Farber for a consult in 2018. Over the previous 21 years, she’d been through two rounds of breast cancer … Read more
Just as the COVID-19 pandemic was sending entire states into lockdown, Jill Bailey learned that her metastatic cervical cancer was beginning to break free of the grip of chemotherapy. It was March 2020. Scans showed that Bailey’s metastatic tumors, which had shrunk in response to chemotherapy and another drug, were slowly starting to grow. A … Read more
Immune therapies declare open season on cancer, rousing immune system cells to take up an attack on tumors. But which immune cells join the hunt, which sit it out, and what happens within immune cells that causes them to go on the offensive? Such questions are especially relevant when immunotherapies show only limited effectiveness against … Read more
Stephanie Davis is a master adapter. When she was initially diagnosed with serous uterine cancer, she found a way to continue working around surgery, radiation, and chemotherapy. Today, she is still adapting — moving from one treatment plan to another as her cancer changes — and is in consultation with her care team to keep … Read more
Ovarian cancer has long been thought of as a cancer that is difficult to treat, particularly after it has recurred or spread. Now, however, patients have more treatment options than ever before. Dana-Farber investigators and others in the field have driven advances in imaging, treatment, and post-treatment maintenance therapy that are helping patients experience longer … Read more
Two things most surprised Jackie Page about her stage III ovarian cancer diagnosis in early 2019. She had no family history of the disease, and she had just turned 52 — a younger age than many women who learn they have it. What most worried her was whether she would have good options for treatment: … Read more
Carol Brown, 80, has been through quite a turbulent 2020. Her much-beloved pastimes, including playing violin in a senior orchestra, book groups, and weekly church services, are now virtual due to the COVID-19 pandemic. The Boston-area resident had to cancel a March trip to visit family out west, and she spent the summer packing up … Read more
Pap smears and HPV testing can be an important part of a person’s regular health care, and the procedure is very simple and quick. What is a Pap smear? A Pap smear, or Pap test, is a procedure that screens for cervical cancer. More specifically, it is used to check for abnormal cells on the … Read more
In their search for better treatments for breast, ovarian, and other cancers, young investigators Jennifer Guerriero, PhD, and Sarah Hill, MD, PhD, rely on a precious commodity — patient tissue samples obtained by surgeons in Dana-Farber’s Susan F. Smith Center for Women’s Cancers. Studies of these normal and cancerous tissues, which are collected, banked, and … Read more
Dana-Farber scientists recently uncovered a potential vulnerability in a form of ovarian cancer notoriously resistant to chemotherapy. Now they’ve opened a clinical trial involving a drug that targets that susceptibility in patients with the disease. The impetus for their research is a type of ovarian cancer with excess copies of the cyclinE1 gene (abbreviated CCNE1). … Read more